Kim, D. D. H. (2023) “Tyrosine kinase inhibitors for the frontline management of CML: an overview”, Canadian Hematology Today. Toronto, Canada, 2(1), pp. 22–26. Available at: http://canadianhematologytoday.com/cht/article/view/2-1-4-kim (Accessed: 28 May 2023).